Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole M Kuderer

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|July 26, 2021
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 EraGary H Lyman, Nicole M Kuderer, Matti Aapro
Cancer Investigation|October 18, 2022
Risk Model Development and Validation in Clinical Oncology: Lessons LearnedGary H Lyman, Pavlos Msaouel, Nicole M Kuderer
The American Journal of Medicine|March 21, 2002
Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysisGary H Lyman, Nicole M Kuderer, Benjamin Djulbegovic
Current Opinion in Hematology|April 16, 2002
Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patientsGary H Lyman, Nicole M Kuderer, Lodovico Balducci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Impact of venous thromboembolism and anticoagulation on cancer and cancer survivalNicole M Kuderer, Thomas L Ortel, Charles W Francis
Cancer Investigation|June 17, 2021
Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent PlasmaGary H Lyman, Aakash Desai, Yan Leyfman, et al.
Cancer|February 22, 2007
Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studiesGary H Lyman, Leon E Cosler, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic reviewNicole M Kuderer, David C Dale, Jeffrey Crawford, et al.
Thrombosis Research|April 29, 2018
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancerGary H Lyman, Eva Culakova, Marek S Poniewierski, et al.
Nature Reviews. Clinical Oncology|October 11, 2022
Mitigating acute chemotherapy-associated adverse events in patients with cancerNicole M Kuderer, Aakash Desai, Maryam B Lustberg, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|July 26, 2021
Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 EraGary H Lyman, Nicole M Kuderer, Matti Aapro
Cancer Investigation|October 18, 2022
Risk Model Development and Validation in Clinical Oncology: Lessons LearnedGary H Lyman, Pavlos Msaouel, Nicole M Kuderer
The American Journal of Medicine|March 21, 2002
Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysisGary H Lyman, Nicole M Kuderer, Benjamin Djulbegovic
Current Opinion in Hematology|April 16, 2002
Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patientsGary H Lyman, Nicole M Kuderer, Lodovico Balducci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Impact of venous thromboembolism and anticoagulation on cancer and cancer survivalNicole M Kuderer, Thomas L Ortel, Charles W Francis
Cancer Investigation|June 17, 2021
Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent PlasmaGary H Lyman, Aakash Desai, Yan Leyfman, et al.
Cancer|February 22, 2007
Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studiesGary H Lyman, Leon E Cosler, Nicole M Kuderer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic reviewNicole M Kuderer, David C Dale, Jeffrey Crawford, et al.
Thrombosis Research|April 29, 2018
Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancerGary H Lyman, Eva Culakova, Marek S Poniewierski, et al.
Nature Reviews. Clinical Oncology|October 11, 2022
Mitigating acute chemotherapy-associated adverse events in patients with cancerNicole M Kuderer, Aakash Desai, Maryam B Lustberg, et al.
Pageof 9